Neonatal sepsis caused by a CTX-M-32-producing Escherichia coli isolate

References

1. Cartelle M., Tomás M. M., Molina F., Moure R., Villanueva R., Bou G. 2004; High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrob Agents Chemother 48:2308–2313 [CrossRef]
   [Google Scholar]
2. Clermont O., Bonacorsi S., Bingen E. 2000; Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66:4555–4558 [CrossRef]
   [Google Scholar]
3. CLSI 2005 Performance Standards for Antimicrobial Susceptibility Testing; 15th Informational Supplement . Approved Standard M100-S15 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
4. Jain A., Roy I., Gupta M. K., Kumar M., Agarwal S. K. 2003; Prevalence of extended-spectrum beta-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol 52:421–425 [CrossRef]
   [Google Scholar]
5. López-Sastre J. B., Fernández Colomer B., Coto-Cotallo G. D., Ramos Aparicio A. The Grupo de Hospitales Castrillo 2005; Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention. Acta Paediatr 94:451–457 [CrossRef]
   [Google Scholar]
6. Matthew A., Harris A. M., Marshall M. J., Ross G. W. 1975; The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J Gen Microbiol 88:169–178 [CrossRef]
   [Google Scholar]
7. Miró E., Mirelis B., Navarro F., Rivera A., Mesa R. J., Roig M. C., Gomez L., Coll P. 2005; Surveillance of extended-spectrum beta-lactamases from clinical samples and faecal carriers in Barcelona, Spain. J Antimicrob Chemother 56:1152–1155 [CrossRef]
   [Google Scholar]
8. Oteo J., Navarro C., Cercenado E., Delgado-Iribarren A., Wilhelmi I., Orden B., Garcia C., Miguelanez S., Pérez-Vazquez M. other authors 2006; Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol 44:2359–2366 [CrossRef]
   [Google Scholar]
9. Romero L., López L., Martinez-Martinez L., Guerra B., Hernandez J. R., Pascual A. 2004; Characterization of the first CTX-M-14-producing Salmonella enterica serotype Enteritidis isolate. J Antimicrob Chemother 53:1113–1114 [CrossRef]
   [Google Scholar]
10. Romero L., López L., Rodríguez-Baño J., Hernández J. R., Martínez-Martínez L., Pascual A. 2005; Long-term study of the frequency of extended spectrum-betalactamases-producing Escherichia coli and Klebsiella pneumoniae isolates. Clin Microbiol Infect 11:625–631 [CrossRef]
    [Google Scholar]
11. Stoll B. J., Hansen N., Higgins R. D., Fanaroff A. A., Duara S., Goldberg R., Laptook A., Walsh M., Oh W., Hale E. The National Institute of Child Health and Human Development 2005; Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002–2003. Pediatr Infect Dis J 24:635–639 [CrossRef]
    [Google Scholar]